Sources for the following lists. ;Very Common (> 10% incidence) adverse effects of<unk> include: * Confusion * Constipation (usually transient, but can persist in some) * Decreased memory * Diarrhea (usually transient, but can persist in some) * Dry mouth * EKG changes — usually benign changes in T waves. * Hand tremor (usually transient, but can persist in some) with an incidence of 27%. If severe, psychiatrist may lower<unk> dosage, change<unk> salt type or modify<unk> preparation from long to short acting (despite lacking evidence for these procedures) or use pharmacological help. * Headache * Hyperreflexia — overresponsive reflexes. * Leukocytosis — elevated white blood cell count * Muscle weakness (usually transient, but can persist in some) * Myoclonus — muscle twitching. * Nausea (usually transient) * Polydipsia — increased thirst. * Polyuria — increased urination. * Renal (kidney) toxicity which may lead to chronic kidney failure * Vomiting (usually transient, but can persist in some) * Vertigo * Weight gain ;Common (1–10%) adverse effects include: * Acne * Extrapyramidal side effects — movement-related problems such as muscle rigidity, parkinsonism, dystonia, etc. * Euthyroid goitre — i.e. the formation of a goitre despite normal thyroid functioning. * Hypothyroidism — a deficiency of thyroid hormone. * Hair loss/hair thinning ;Unknown: * Sexual dysfunction * Hypoglycemia<unk> is known to be responsible for 1–2 kg of weight gain. Weight gain may be a source of low self-esteem for the clinically depressed. In addition to tremors,<unk> treatment appears to be a risk factor for development of parkinsonism symptoms, although the causal mechanism remains unknown. Most side effects of<unk> are dose-dependent. The lowest effective dose is used to limit the risk of side effects. Hypothyroidism The rate of hypothyroidism is around six times higher in people who take<unk>  Low thyroid hormone levels in turn increase the likelihood of developing depression. People taking<unk> thus should routinely be assessed for hypothyroidism and treated with synthetic thyroxine if necessary. Because<unk> competes with the antidiuretic hormone in the kidney, it increases water output into the urine, a condition called nephrogenic diabetes insipidus. Clearance of<unk> by the kidneys is usually successful with certain diuretic medications, including amiloride and triamterene. It increases the appetite and thirst ("polydypsia") and reduces the activity of thyroid hormone (hypothyroidism). The latter can be corrected by treatment with thyroxine and does not require the<unk> dose to be adjusted.<unk> is also believed to permanently affect renal function, although this does not appear to be common. Pregnancy and breast feeding<unk> is a teratogen, causing birth defects in a small number of newborn babies. Case reports and several retrospective studies have demonstrated possible increases in the rate of a congenital heart defect known as Ebstein's anomaly, if taken during a woman's pregnancy. As a consequence, fetal echocardiography is routinely performed in pregnant women taking<unk> to exclude the possibility of cardiac anomalies. Lamotrigine seems to be a possible alternative to<unk> in pregnant women for the treatment of acute bipolar depression or for the management of bipolar patients with normal mood. Gabapentin and clonazepam are also indicated as antipanic medications during the childbearing years and during pregnancy. Valproic acid and carbamazepine also tend to be associated with teratogenicity. While it appears to be safe to use while breastfeeding a number of guidelines list it as a contraindication including the British National Formulary. Kidney damage<unk> has been associated with several forms of kidney injury. It is estimated that impaired urinary concentrating ability is present in at least half of individuals on chronic<unk> therapy, a condition called<unk> induced nephrogenic diabetes insipidus. Continued use of<unk> can lead to more serious kidney damage in an aggravated form of diabetes insipidus. Chronic kidney disease caused by<unk> has not been proven with various contradicting results presented by a 2018 review. In rare cases, some forms of<unk> caused kidney damage may be progressive and lead to end-stage kidney failure with a reported incidence of 0.2% to 0.7%. Hyperparathyroidism<unk> associated hyperparathyroidism is the leading cause of hypercalcemia in<unk> treated patients.<unk> may lead to exacerbation of pre-existing primary hyperparathyroidism or cause an increased set-point of calcium for parathyroid hormone suppression, leading to parathyroid hyperplasia.
Lithium 
Chlortalidone
Methylphenidate
Sertraline
Citalopram
Paliperidone
Loprazolam
Dexmethylphenidate